Directorate change

Summary by AI BETAClose X

Empresaria Group plc announced that Tim Anderson is stepping down as CFO and from the Board with immediate effect, following a prior notification on November 12, 2025. Anderson will remain available to assist the finance team with the audited results for the year ended December 31, 2025. The Chair expressed gratitude for Anderson's eight years of contribution to the company.

Disclaimer*

Empresaria Group PLC
22 January 2026
 

22 January 2026

 

Empresaria Group plc

("Empresaria" or the "Company")

 

Directorate change

 

Empresaria Group plc (AIM: EMR), the international specialist staffing group, announces that, further to the Company's notification on 12 November 2025, Tim Anderson is stepping down from his role as CFO and from the Board with immediate effect. Tim will remain available to assist the Company's finance team in relation to the Company's audited results for the year ended 31 December 2025.

 

Joost Kreulen, Chair of Empresaria, commented:

 

"I want to thank Tim for his contribution to Empresaria over the last eight years and to wish him well for the future."

 

- Ends -

 

 

Enquiries:

Empresaria Group plc
Joost Kreulen, Chair

via Alma PR

Allenby Capital Limited (Nominated Adviser and Joint Broker)
Nick Naylor / Jeremy Porter / Vivek Bhardwaj

020 3328 5656

Alma Strategic Communications (Financial PR)
Sam Modlin / Rebecca Sanders-Hewett / Will Merison

020 3405 0205
empresaria@almastrategic.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings